CD8A and neoplasm: Initiation of TH1 type CD4+ T cell responses via DC-derived cytokines such as IL-12 is a crucial component in the anti-tumor response, reinforcing the expansion of CD8+ T cells and licensing CTLs for (tumor) killing (10).